In 2023, the re-import value of therapeutic respiration apparatus to China was at an observed baseline before forecasted increments. From 2024 onwards, the sector witnesses a steady year-on-year growth: 2.84% from 2024 to 2025, 2.71% from 2025 to 2026, 2.58% from 2026 to 2027, and a 2.47% increase by 2028. Over these five years, the compound annual growth rate (CAGR) is a consistent 2.65%, indicating robust expansion.
Future trends to watch for in this domain include:
- The impact of emerging respiratory technologies and their influence on demand dynamics.
- Chinese healthcare reforms and their potential to increase domestic production, affecting re-import needs.
- Macro-economic variables such as trade policies and global supply chain stability that could alter forecast accuracy.
